< Back to previous page
Researcher
Herlinde Dumez
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Oncology (Division)
Member
From1 Oct 2005 → Today
Publications
51 - 60 of 64
- A case series of embryonal rhabdomyosarcoma of the head and neck in adults(2010)
Authors: Johan Wagemans, Benoit Beuselinck, Sandra Nuyts, Raf Sciot, Pierre Delaere, Vincent Vander Poorten, Herlinde Dumez, Bob Hermans, Patrick Schöffski, Walter Van den Bogaert, et al.
Pages: 404 - 410 - A phase I-II study of everolimus (RAD001) in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors(2010)
Authors: Patrick Schöffski, Herlinde Dumez
Pages: 1990 - 1998 - Phase II Study of Biweekly Plitidepsin as Second-Line Therapy for Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium(2009)
Authors: Herlinde Dumez, Patrick Schöffski
Pages: 451 - 463 - Six cases of testicular cancer associated with sarcoidosis: a clinical challenge(2009)
Authors: Herlinde Dumez, Patrick Schöffski
Pages: 447 - 447 - Docetaxel plus oblimersen sodium (Bcl-2 antisense oligonucleotide): an EORTC multicenter, randomized phase II study in patients with castration-resistant prostate cancer(2009)
Authors: Herlinde Dumez, Hendrik Van Poppel
Pages: 1264 - 1269 - Phase II Randomized Study of Plitidepsin (Aplidin), Alone or in Association with L-carnitine, in Patients with Unresectable Advanced Renal Cell Carcinoma(2009)
Authors: Patrick Schöffski, Herlinde Dumez
Pages: 57 - 70 - Outcome of three Phase I trials of the marine compound ES-285 (3 hour infusion) in patients with refractory solid tumors(2008)
Authors: Patrick Schöffski, Herlinde Dumez
Pages: 56 - 56 - Preliminary results of a Phase I accelerated dose-escalation, pharmacokinetic and pharmacodynamic study of PF-03814735, an oral Aurora kinase A and B inhibitor, in patients with advanced solid tumors(2008)
Authors: Patrick Schöffski, Herlinde Dumez
Pages: 91 - 91 - A Phase I single dose escalation study of the novel Polo-like kinase 1 inhibitor BI 6727 in patients with advanced solid tumours(2008)
Authors: Patrick Schöffski, Herlinde Dumez
Pages: 14 - 15 - Early phase II trial of oral vorinostat in relapsed or refractory breast, colorectal, or non-small cell lung cancer(2008)
Authors: Johan Vansteenkiste, Eric Van Cutsem, Herlinde Dumez, Patrick Schöffski
Pages: 483 - 488